Kim R. Tsuchimoto - Dec 31, 2022 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Financial Officer
Signature
/s/ Kim R. Tsuchimoto
Stock symbol
MNPR
Transactions as of
Dec 31, 2022
Transactions value $
-$6,089
Form type
4
Date filed
1/3/2023, 03:03 PM
Previous filing
Oct 3, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNPR Common Stock Options Exercise +5.07K +34.29% 19.8K Dec 31, 2022 Direct F1
transaction MNPR Common Stock Tax liability -$4.9K -2.07K -10.42% $2.37 17.8K Dec 31, 2022 Direct
transaction MNPR Common Stock Options Exercise +1.23K +6.92% 19K Jan 1, 2023 Direct F1
transaction MNPR Common Stock Tax liability -$1.19K -502 -2.64% $2.37 18.5K Jan 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Restricted Stock Units Options Exercise $0 -5.07K -8.31% $0.00 55.9K Dec 31, 2022 Common Stock 5.07K Direct F1, F2, F3
transaction MNPR Restricted Stock Units Options Exercise $0 -1.23K -49.98% $0.00 1.23K Jan 1, 2023 Common Stock 1.23K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired on vesting and settlement of restricted stock units.
F2 On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
F3 On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
F4 On January 31, 2020, the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.